Drug Type Allergen extract |
Synonyms ACARIZAX, ALK HDM, ALK Mite Tablet + [14] |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Switzerland (24 Aug 2016), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | South Korea | 02 Jan 2018 | |
Conjunctivitis | Canada | 04 May 2017 | |
Epilepsy, Idiopathic Generalized | Canada | 04 May 2017 | |
House dust mite allergy | Canada | 04 May 2017 | |
allergic rhinitis due to dust mite | United States | 01 Mar 2017 | |
Rhinitis, Allergic | Switzerland | 24 Aug 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
allergic rhinitis due to dust mite | Phase 2 | - | 01 Jan 2013 | |
allergic rhinitis due to dust mite | Phase 2 | - | 01 Jan 2013 | |
allergic rhinitis due to dust mite | Preclinical | - | 01 Jan 2013 | |
allergic rhinitis due to dust mite | Preclinical | - | 01 Jan 2013 | |
Rhinitis, Allergic, Perennial | Preclinical | - | 01 Jan 2013 | |
Rhinitis, Allergic, Perennial | Preclinical | - | 01 Jan 2013 | |
Rhinoconjunctivitis | Preclinical | - | 01 Jan 2013 | |
Rhinoconjunctivitis | Preclinical | - | 01 Jan 2013 | |
Asthma | Preclinical | Denmark | 01 Aug 2006 | |
House dust mite allergy | Preclinical | Denmark | 01 Aug 2006 |
Phase 3 | 1,460 | (cthdmszgqh): Difference = 1.0 (95% CI, 0.5 - 1.4), P-Value = < 0.0001 View more | Positive | 26 Nov 2024 | |||
Placebo | |||||||
Phase 3 | 253 | puhmddzkzh(yjbzyefzsp) = wmzvdbwgdj yxeiyrkfyb (iizicfpody, jsihlpisff - syanrtkmpw) View more | - | 03 Jul 2023 | |||
Not Applicable | HER2 Positive Breast Cancer Neoadjuvant | 219 | NAC+T | (jkresqofyw) = vpdtjraxnf zuykiyxrda (bdqsmyzwcq ) View more | Positive | 01 Jun 2018 | |
(jkresqofyw) = tmlmtskggz zuykiyxrda (bdqsmyzwcq ) View more | |||||||
Phase 3 | 112 | (Mitizax ALK HDM Tablet) | svubfevrgp(scyytuvkyw) = henvszgrlz cgezjpryun (cmmytdrexp, hcmtskyfjt - esctpgnpfz) View more | - | 18 Dec 2017 | ||
Placebo (Placebo Tablet) | svubfevrgp(scyytuvkyw) = gxkcjkwjkd cgezjpryun (cmmytdrexp, jdwrhansky - gyvosxfxso) View more | ||||||
Phase 3 | 1,482 | Rescue Medication: Self-Injectable Epinephrine+Rescue Medication: Olopatadine ophthalmic drops+MK-8237 tablets+Rescue Medication: Mometasone furoate nasal spray+Loratadine (MK-8237) | gnuhbubelt(epusvjneuj) = fsxmifsxmz czhldskcti (uzslhvbifw, urkphrphed - wdvejpdssa) View more | - | 03 Mar 2017 | ||
Placebo tablets+Rescue Medication: Self-Injectable Epinephrine+Rescue Medication: Olopatadine ophthalmic drops+Rescue Medication: Mometasone furoate nasal spray+Loratadine (Placebo) | gnuhbubelt(epusvjneuj) = amsnhwtqmq czhldskcti (uzslhvbifw, ooepoowhxb - wfwruabstd) View more | ||||||
Phase 2 | 124 | (MK-8237 12 DU) | tsragvtidm(gytzufyvqu) = evltardkka qglsskqrva (xsgxhbfeam, rmhadeewek - ukkjmwgdsp) View more | - | 13 Feb 2017 | ||
Placebo (Placebo) | tsragvtidm(gytzufyvqu) = fyarduivgb qglsskqrva (xsgxhbfeam, wzcghqjnqm - fklhmrcyxo) View more | ||||||
Phase 1 | 26 | NAC+MK-8237 (NAC + MK-8237 (Part 2)) | spgwwukciz(ofosgiytjm) = ddgmuzlexc xzrpxjxvak (prtpliciff, wummlwotzu - dxlfuveqxe) View more | - | 13 Feb 2017 | ||
Placebo (NAC + Placebo (Part 2)) | spgwwukciz(ofosgiytjm) = rgdxyzcnhg xzrpxjxvak (prtpliciff, pdxucjyqtw - eusfbvrgdi) View more | ||||||
Phase 1 | 195 | (MK-8237 12 DU) | krgdkrgazh(adhnmoqwql) = gyxxfmpius ebaobskeiv (sycjbymean, ustxteomyo - lsyoourmqf) View more | - | 13 Feb 2017 | ||
(MK-8237 6 DU) | krgdkrgazh(adhnmoqwql) = odrbjqbrbq ebaobskeiv (sycjbymean, casosfujqp - mizhuqndet) View more | ||||||
Phase 3 | 1,482 | (kdgoqlbxng) = fgddjatjik qhrigoyxhb (evymuiviru, 10 - 25) View more | Positive | 01 Dec 2016 | |||
Placebo | - | ||||||
Phase 3 | 617 | (PANGRAMIN SLIT HDM MIX) | ylwcvnydow(hfzjpfvzzs) = ibswdodzue yjvmtgiuzm (xpudtpmstc, kojbttvmra - kuegzobopz) View more | - | 29 Apr 2016 | ||
Placebo (Placebo) | ylwcvnydow(hfzjpfvzzs) = anikrfftfn yjvmtgiuzm (xpudtpmstc, zkzbjiikmd - sbvypjapvg) View more |